Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
ANGO
— AngioDynamics, Inc.
NASDAQ
FULL STOCK PAGE →
Q3 2026 Earnings Call Summary
APR 2, 2026
REVENUE
$78.4M
-1.3%
NET MARGIN
-10.3%
-2.3 PTS
EPS
-$0.19
-26.7%
FREE CASH FLOW
-$4.1M
-197.3%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →